Through TMT as one of isobaric labeling tags-based quantitative proteomic analysis and subsequent verification using ELISA, we especially identified three novel biomarkers associated with CVD risks in patients with psoriasis; CALD1, ZYX, and MNDA. Here, CALD1 is linked to psoriasis.